Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Scope Of Practice topic
No spam. Unsubscribe anytime.
Board tables question on whether podiatrists may administer neuromodulators and dermal fillers
Summary
A licensee asked whether podiatry physicians may administer Clostridium botulinum–related neuromodulators and dermal or soft‑tissue fillers without regulations required by NRS 635.086; the Board tabled the matter for further legal and staff research at a later meeting.
The Board considered a licensee question about whether podiatry physicians may administer neuromodulators derived from Clostridium botulinum and dermal or soft‑tissue fillers absent specific regulations under NRS 635.086. Executive Director Carolyn J. Cramer summarized the question for members and Senior Deputy Attorney General Henna Rasul advised that the Board should table the matter pending further research into the regulatory and statutory requirements.
The minutes record that the matter was tabled for staff to do further research and return the question at a later meeting. No formal policy change or guidance was issued at the Jan. 12 session.
